Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Anti-viral pneumonia medicine and preparation method thereof

A drug and pneumonia technology, which is applied in the field of antiviral pneumonia drugs and their preparation, can solve the problems of failing to meet the expectations and requirements of consumers' health, the inability of the human body to fully and effectively absorb, the loss of purity, and drug efficacy, and achieve the goal of improving the quality of human cells. Immunity and non-specific immunity, prevention of upper respiratory tract infection, no cytotoxic effect

Inactive Publication Date: 2021-03-26
王丽敏
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Although there are products for the treatment of viral pneumonia on the market at present, some of which have certain effects on relieving cough and asthma, clearing away heat and eliminating phlegm, and reducing inflammation and analgesia, they have not yet met the expectations and requirements of consumers for health. The product has the following disadvantages:
[0004] (1) Limitations of existing technologies: The current domestic medical technology and production technology for the treatment of viral pneumonia and other lung diseases are limited, resulting in a large loss of purity and efficacy when purifying drug concentration and active ingredients;
[0005] (2) Complex ingredients, poor effect, and strong dependence: products for the treatment of viral pneumonia and other lung diseases require very high technology, complex ingredients, loss of drug efficacy or technical defects will lead to poor effect; and long-term use It is easy to develop drug resistance, and may produce joint pain, diarrhea, headache, nausea, vomiting, dizziness, insomnia, menstrual disorders or coma, confusion, hallucinations, epilepsy and other central nervous system symptoms, as well as liver damage, kidney damage, pulmonary Serious side effects such as multiple local infections, decreased immunity, and cancer can damage the body;
[0006] (3) Large side effects: Western medicines have large side effects, treat the symptoms but not the root cause, and are prone to relapse, so the gain outweighs the gain;
[0007] (4) There are many taboos in the use of traditional Chinese medicine, which is very troublesome;
[0008] (6) Without a good carrier, the human body cannot fully and effectively absorb it. In order to solve the problems existing in the above technologies, a new technical solution is proposed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The weight of each component of the medicine is 1 frost mulberry leaf, 1 g perilla leaf, 10 g Artemisia annua, 10 g kudzu root, 10 g dried reed root, 10 g Houttuynia cordata, 10 g forsythia, 5 g double flower, 5 g almond, 5 g peucedanum, Bellflower 5g, Zhejiang Fritillaria 10g, Burdock 5g, Yuanshen 10g, Radix Ginseng 10g, Divine Comedy 10g, Stir-fried Atractylodes Rhizoma 1g, Huoxiang 2-15g, Guanzhong 5g, White Cardamom 3g, Yun Fuling 10g and Raw Licorice 1g.

Embodiment 2

[0024] The weight of each component of the medicine is 9g of frost mulberry leaves, 9g of perilla leaves, 12g of Artemisia annua, 15g of kudzu root, 30g of dried reed root, 30g of Houttuynia cordata, 15g of forsythia, 15g of double flower, 9g of almond, Hu 9g, Campanulaceae 9g, Fritillaria 15g, Arctium 15g, Yuanshen 15g, Radix Ginseng 30g, Divine Comedy 15g, Stir-fried Atractylodes Rhizoma 9g, Huoxiang 9g, Guanzhong 9g, White Cardamom 5g, Yun Fuling 30g and Raw Licorice 3g .

Embodiment 3

[0026] The weight of each component of the medicine is 10g of frost mulberry leaves, 10g of perilla leaves, 30g of Artemisia annua, 20g of kudzu root, 50g of dried reed root, 50g of Houttuynia cordata, 20g of forsythia, 20g of double flower, 20g of almond, 10g of peucedanum, Bellflower 15g, Zhejiang Fritillaria 30g, Burdock 20g, Yuanshen 20g, Radix Ginseng 40g, Divine Comedy 20g, Raw Fried Atractylodes Rhizoma 10g, Huoxiang 15g, Guanzhong 15g, White Cardamom 8g, Yun Fuling 50g and Raw Licorice 5g.

[0027] Above three embodiments all adopt following method to prepare:

[0028] A kind of preparation method of antiviral pneumonia medicine, the method comprises the following steps:

[0029] Step 1. Take frost mulberry leaves, perilla leaves, Artemisia annua, kudzu root, dried reed root, houttuynia cordata, forsythia, double flower, Peucedanum, bellflower, Fritillaria, burdock, root ginseng, sand ginseng, divine comedy , Huoxiang and Guanzhong to remove impurities, remove residua...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An anti-viral pneumonia medicine relates a medicament for treating viral pneumonia. The medicine consists of folium mori, folium perillae, herba artemisiae, radix puerariae, dried rhizoma phragmitis,herba houttuyniae, fructus forsythiae, flos lonicerae, semen armeniacae amarum, radix peucedani, radix platycodi, bulbus fritillariae thunbergii, fructus arctii, radix scrophulariae, radix adenophorae, massa medicata fermentata, roasted rhizoma atractylodis macrocephalae, herba agastaches, rhizoma osmundae, fructus amomi rotundus, poria and radix glycyrrhizae. The anti-viral pneumonia medicine issimple to use, has a rapid effect, basically takes effect by one dose, has excellent effects of treating lung diseases including viral pneumonia, cough, expectoration, rhinitis, laryngitis, trachitis,bronchitis, pneumonia and the like and preventing and treating lung cancer, and does not have any toxic or side effects. According to the anti-viral pneumonia medicine, the ancient processing technology and the like are adopted to perform high-purity extraction on biological components beneficial to resisting viruses, relieving cough and asthma, clearing heat, eliminating phlegm, diminishing inflammation, easing pain, choleresis increasing, protecting liver, improving immunity and resisting cancers, and thus, the biological components are easily absorbed by the human body.

Description

Technical field: [0001] The invention relates to a medicine for treating toxic pneumonia, in particular to an antiviral pneumonia medicine and a preparation method thereof. Background technique: [0002] Viral pneumonia is bronchopneumonia caused by a variety of viral infections, the common one is influenza virus, followed by parainfluenza virus, cytomegalovirus, adenovirus, rhinovirus, coronavirus and some enteroviruses, such as Cosa Qi, echo virus, etc., as well as chickenpox, rubella, measles virus, respiratory syncytial virus. In addition to these common viruses, infections with emerging viruses such as acute respiratory syndrome coronavirus (SARS virus), Middle East respiratory syndrome coronavirus (MERS virus) and avian influenza virus have increased in severity and lethality in recent years , pose a great risk to human health. The main clinical manifestations of viral pneumonia are fever, headache, body aches, dry cough, and lung infiltration. Severe pneumonia can ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9064A61K9/08A61P11/00A61P31/14A61P35/00A61P11/02A61P11/14A61P11/04A61P11/10
CPCA61K9/0095A61K36/00A61K36/076A61K36/12A61K36/23A61K36/28A61K36/282A61K36/284A61K36/34A61K36/342A61K36/346A61K36/355A61K36/484A61K36/488A61K36/532A61K36/535A61K36/605A61K36/634A61K36/736A61K36/78A61K36/808A61K36/8966A61K36/899A61K36/9064A61P11/00A61P11/02A61P11/04A61P11/10A61P11/14A61P31/14A61P35/00A61K2300/00
Inventor 王丽敏
Owner 王丽敏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products